单细胞转录组学剖析了骨髓发育性瘤中造血干细胞的转录组变化
Xiangzong Zeng1,2, Yichen Wang2, Min Dai3
1Department of Hematology, Affiliated Qingyuan Hospital, Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, 511518, China.
Journal of translational medicine
|April 17, 2024
概括
酸氨基醇特异性脂酶Cββ1 (PLCB1) 驱动髓状瘤的进展. 这项研究揭示了PLCB1的存在.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 骨髓发育性瘤 (MDS) 是一种克隆性造血干细胞疾病.
- MDS的特点是无效的造血和转化为急性髓性白血病 (AML) 的高风险.
- 人们对MDS的潜在病原体及其向AML的进展仍然不完全了解.
研究的目的:
- 在MDS.中研究血造干细胞和原生细胞 (HSPCs) 的分化轨迹.
- 阐明驱动MDS中白血病转变的机制.
- 为了确定MDS病变发生的关键分子参与者.
主要方法:
- 来自MDS患者的HSPC单细胞RNA-Seq数据的生物信息学分析.
- 伪时空排序来重建分化路径.
- 使用患者样本进行基因表达分析和验证.
- 使用PLCB1抑制剂进行体外功能测试.
主要成果:
- 在MDS患者中扩大了常见髓状原体 (CMPs),这些患者有过多的爆发 (EB) /二次AML.
- MDS CMPs表现出一个活跃的增殖状态,具有上调的增殖相关基因,包括MAML3和PLCB1.
- 在MDS-EB患者中,PLCB1表达显著更高,并且与AML转化风险增加相关.
- 抑制PLCB1抑制了增殖,诱导细胞循环停止,并在体外促进了细胞亡.
结论:
- 在MDS转化为白血病的过程中,PLCB1起着至关重要的作用.
- 对HSPCs的转录组分析为MDS进展提供了洞察力.
- 准PLCB1可能为MDS提供治疗策略.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K


